Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMK8W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,465
Award facts
- Contract value 100% obligated
- $32,464.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,464.79 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 29, 2026, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 30, 2026. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under a larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which represents a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Dupixent is a biologic medication used primarily for treating moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. As the sole awardee under the DLA's primary pharmaceutical prime vendor contract, AmerisourceBergen demonstrates its established capability to meet federal procurement requirements and support military treatment facilities and veterans' healthcare programs with essential pharmaceutical supplies.
Quick answers
Who was awarded contract SPE2DR26FMK8W?
SPE2DR26FMK8W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FMK8W worth?
The government has obligated $32,465 on SPE2DR26FMK8W.
Is contract SPE2DR26FMK8W an order under another contract?
Yes. SPE2DR26FMK8W is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK8W competed?
The extent of competition for SPE2DR26FMK8W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award